J Biol Chem, Vol. 274, Issue 47, 33320-33326, November 19, 1999
Reactivity of the Two Essential Cysteine Residues of the
Periplasmic Mercuric Ion-binding Protein, MerP*
Justin
Powlowski
and
Lena
Sahlman
From the Department of Chemistry and Biochemistry, Concordia
University, Montreal, Quebec H3G 1M8, Canada
 |
ABSTRACT |
Reactivities of the two essential cysteine
residues in the heavy metal binding motif,
MTC14AAC17, of the periplasmic
Hg2+-binding protein, MerP, have been examined. While
Cys-14 and Cys-17 have previously been shown to be
Hg2+-binding residues, MerP is readily isolated in an
inactive Cys-14-Cys-17 disulfide form. In vivo results
demonstrated that these cysteine residues are reduced in the periplasm
of Hg2+-resistant Escherichia coli.
Denaturation and redox equilibrium studies revealed that reduced MerP
is thermodynamically favored over the oxidized form. The relative
stability of reduced MerP appears to be related to the lowered thiol
pKa (5.5) of the Cys-17 side chain. Despite its
much lower pKa, the Cys-17 thiol is far less
accessible than Cys-14, reacting 45 times more slowly with
iodoacetamide at pH 7.5. This is reminiscent of proteins such as
thioredoxin and DsbA, which contain a similar C-X-X-C motif, except in those cases the more
exposed thiol has the lowered pKa. In terms of MerP
function, electrostatic attraction between Hg2+ and the
buried Cys-17 thiolate may be important for triggering the structural
change that MerP has been reported to undergo upon Hg2+
binding. Control of cysteine residue reactivity in heavy metal binding
motifs may generally be important in influencing specific metal-binding
properties of proteins containing them.
 |
INTRODUCTION |
Bacterial resistance to mercuric ion is mediated by the
polypeptides encoded by mer operons. Although the specific
number of required polypeptides varies according to species, all
operons appear to encode: one or more regulatory proteins (MerR, MerD); a periplasmic mercuric ion-binding protein (MerP); one or more integral
membrane proteins thought to be required for mercuric ion transport
(MerT, MerC); and a cytoplasmic mercuric ion reductase (MerA), which
reduces intracellular Hg2+ ion to a volatile form,
Hgo (reviewed in Refs. 1 and 2).
The mer operon-encoded periplasmic protein, MerP, from the
transposon Tn21 has a molecular mass of 7500 Da after
removal of a periplasmic signal sequence (1, 3, 4). There are no tryptophan or histidine residues in the mature protein and only two
cysteine residues, at positions 14 and 17. MerP has previously been
shown to specifically bind Hg2+ in the presence of external
thiols via these two cysteine residues (4, 5). The recently published
structure of MerP revealed that Cys-14 is surface-exposed and Cys-17 is
buried inside the protein; once Hg2+ is bound to the
thiols, they are both surface-exposed (6). The structural change that
accompanies Hg2+ binding has been proposed to be important
for the interaction of Hg2+-loaded MerP with the inner
membrane transport protein(s). Although it has been postulated that the
function of MerP is to transfer Hg2+ to the mer
operon-encoded integral membrane proteins for passage across the inner
membrane (7), current evidence suggests that MerP is dispensable for
transport. Instead, it may function as a mercuric ion "sponge" to
protect components of the periplasm from the toxic effects of this
heavy metal (8, 9).
MerP has been shown to exist in vitro in oxidized
(disulfide) and reduced (dithiol) forms, but the redox state of the
protein in the bacterial periplasm has never been reported. In order to bind Hg2+ via its thiols, MerP should be present in the
reduced form. However, it is generally accepted that the periplasm is
an oxidizing environment, with proteins such as DsbA and DsbB
catalyzing disulfide bond formation in many bacterial periplasmic
proteins (reviewed in Ref. 10). In this investigation, the redox state
in vivo and the reactivity of the thiol groups of MerP have
been investigated.
 |
MATERIALS AND METHODS |
Chemicals--
All chemicals were of the highest purity
available. 203HgCl2 was purchased from Amersham
Pharmacia Biotech (Stockholm, Sweden).
Bacterial Strains and Manipulations--
The gene,
merP from transposon Tn21, was expressed in
E. coli BL21(DE3) (11) from the T7 promoter of pCA (4), or
using the plasmid pDU1003, which contains the complete
Hg2+-inducible mer operon (12). Expression of
the MerP variants C14A, C14S, C17A, and C17S was as described
previously (5). The C17D variant was constructed using the QuikChange
method (Stratagene). The template was pCAmerP, and the
mutagenic primers were 5'-GACTTGCGCCGCGGACCCGATCACAGTC-3' and its
complement, obtained from Biocorp Inc. (Montreal, Canada). Nucleotide
sequence analysis of the complete gene was performed at the Sheldon
Biotechnology Center (Montreal, Canada), and confirmed the presence of
the desired mutation.
In all cases, cultures were grown in LB medium, plus the appropriate
antibiotic, to an A600 of 0.8-1.0 before
induction. Induction from T7-based plasmids was achieved by adding
isopropyl-1-thio-
-D-galactopyranoside to a concentration
of 0.5 mM, followed by further growth for 3 h at
37 °C. For induction from pDU1003, HgCl2 was added to an initial concentration of 20 µM, and a second aliquot (20 µM) was added after an additional 1 h of growth at
37 °C.
Release of periplasmic proteins was achieved either using chloroform
(13) or lysozyme-EDTA (14). In order to examine the redox state of
MerP, iodoacetate was included to trap free thiols at all stages of the
release procedure (14). Alternatively, cultures were processed by
precipitation of cellular proteins using trichloroacetic acid, followed
by dissolution of the precipitated proteins in 6 M urea,
containing iodoacetic acid, essentially as described (15).
Proteins and Protein Modification--
MerP and all of the
variants were purified in the absence of added cysteine, as described
previously; chromatography on hydroxylapatite was usually included as a
final step (4, 5). Since all of these proteins were from recombinant
sources never exposed to mercuric ion, residual bound Hg2+
is not a concern in any experiments done with purified MerP or variants.
When required, wild-type MerP was reduced either using dithiothreitol
(DTT)1 or
tris-(2-carboxyethyl)phosphine (TCEP), under conditions described in
the text. Modification of MerP by iodoacetate was accomplished at room
temperature in the presence of sodium iodoacetate (0.1 M)
in 0.1 M Tris-HCl, pH 8.1. The modification reactions were generally run in the dark for 10-30 min, and then placed on ice before
analysis. In some cases, urea was included during the modification reaction.
Protein concentrations were estimated by the method of Gill and von
Hippel (16).
Thiol Group Titration--
The pKa values of
cysteine thiol groups were monitored by the change in absorbance at 240 nm accompanying ionization (17). Over the pH range tested, the oxidized
form of MerP exhibited no absorbance change at 240 nm, indicating that
the changes observed during pH titration were due to thiol group
ionization. In preparation for these experiments, samples were reduced
at room temperature for 1-1.5 h with a 10-fold excess of TCEP. Excess
reductant was removed by gel filtration on Econo-Pac10DG columns
(Bio-Rad) equilibrated with 10 mM acetate buffer, pH 5.0, containing 0.2 mM EDTA. Samples were then concentrated
using Centricon-3 (Amicon) ultrafiltration. Absorbance measurements
were made by diluting a 30-50-fold concentrated solution of protein
into 0.1 M acetate-MES-Tris buffers of varying pH (18)
containing 0.1 M KCl. Water was added to give final buffer
and KCl concentrations of 0.05 M each, and protein
concentrations in the range of 50-120 µM. Spectra for
each sample, contained in a microcell, were scanned immediately in the
region 220-400 nm. A separate base line was recorded for each buffer
prior to scanning the protein solution.
Thiol pKa values were estimated by non-linear
least-squares fitting of plots of extinction (240 nm) versus
pH using equations for 1 or 2 pKa values as supplied
with Grafit 3 (Erithacus Software, Middlesex, United Kingdom).
Determination of Redox Potential--
The redox equilibrium
constant of MerP with glutathione, Kox, is shown
in Equation 1.
|
(Eq. 1)
|
GSH and GSSG are the oxidized and reduced forms of glutathione,
respectively. Kox was estimated after incubation
of MerP with various ratios of oxidized and reduced glutathione,
essentially as described elsewhere (19). Briefly, MerPox
(90 µM) was incubated anaerobically for 24 h in 0.1 M potassium phosphate buffer, pH 7.5, containing EDTA (1 mM), KCl (0.1 M), GSH (10.4 mM),
and various concentrations of GSSG. Oxidized and reduced forms of MerP
were quantitated by HPLC (see below) after quenching to pH 2 with HCl.
Data were fitted to Equation 2 (19, 20).
|
(Eq. 2)
|
where R = [GSH]/[GSSG], and
Kmix is the equilibrium constant between
glutathione and the MerP-glutathione mixed disulfide. Only small
quantities (
10%) of mixed disulfide accumulated, and a
Kmix of 0.56 was estimated from a plot of
[MerP-SSG]/MerPred versus [GSSG]/[GSH], as
described in Ref. 21.
The standard redox potential was calculated using the Nernst equation
and a standard redox potential of +0.24 V (22) for the glutathione
redox pair.
Quantitation of Oxidized, Reduced, and Mixed Disulfides of
MerP--
Different forms of MerP were quantitated using HPLC. The
reduced, oxidized, and modified forms of the protein were separated on
a Vydac C-18 Protein and Peptide column (catalog no. 218TP54) at a flow
rate of 1.5 ml/min. Samples were acidified to a pH of approximately 2 with HCl, and injected onto the column, which was equilibrated with
0.1% trifluoroacetic acid/water (68%):0.1% trifluoroacetic
acid/acetonitrile (32%). After 2 min a linear gradient was run over 20 min to 0.1% trifluoroacetic acid/water (63%):0.1% trifluoroacetic
acid/acetonitrile (37%), and then the column was washed for 3 min with
this solvent. Quantitation was achieved by calculating peak areas after
detection at 215 nm.
Denaturation of MerP--
MerP was denatured with different
concentrations of guanidine HCl in 0.1 M
Tris-SO4 buffer, pH 7.5, for 18 h at room temperature. The protein concentration was approximately 15 µM;
guanidine hydrochloride stock solution concentrations were determined
by refractometry (23). For denaturation of MerPred, 2 mM DTT was added to reduce a stock solution of protein.
Samples were transferred to a glove box, whereupon the protein was
diluted in 0.1 M Tris-SO4 buffer, pH 7.5, containing 1-2 mM DTT and different concentrations of guanidine HCl. The samples were left for 18 h under anaerobic conditions. Samples of single cysteine variants of MerP were prepared similarly, but were not anaerobic. CD spectra were recorded at 23 °C
using a Jasco J-710 spectropolarimeter. Each spectrum was an
average of five accumulations, with step size 0.2 nm and
bandwidth 1 nm.
Data analysis was carried out by non-linear fitting, using Sigmaplot 4 (SPSS Scientific, Chicago, IL), of measured ellipticities at different
guanidine HCl concentrations as described (24-26). Fraction folded was
calculated using the fitted parameters (25).
Kinetics of Iodoacetamide Reactions with MerP and
Variants--
Reactions between iodoacetamide and MerP were carried
out anaerobically at 25 °C in 0.1 M phosphate buffer, pH
7.5, containing 1 mM EDTA and 0.1 M KCl. MerP
or variants (75-160 µM), prepared as described for the
pH titration experiments, were incubated with various concentrations of
iodoacetamide. At different times, reactions were quenched by
acidification with HCl to a pH of approximately 2, and analyzed
immediately by HPLC as described above.
Data were analyzed using non-linear least-squares fitting to a single
exponential using Sigmaplot 4. In the case of wild-type MerPred, the pseudo-first order rate constants obtained at
3 and 30 mM iodoacetamide were divided by iodoacetamide
concentration to estimate second order rate constants; data for the
variants were obtained at several iodoacetamide concentrations. The
pH-independent rate constant, kS-, for
reactivity of a thiolate with iodoacetamide was estimated using
Equation 3.
|
(Eq. 3)
|
Analytical Techniques--
Quantitation of protein thiol groups
was performed using Ellman's reagent (27). UV-visible absorbance
spectra were acquired using a Philips 8715 spectrophotometer.
Electrospray ionization mass spectrometry was performed using a
Finnigan SSQ 7000 single quadrupole mass spectrometer interfaced to a
liquid chromatograph. Samples were introduced via a C-18 (5 µm)
column (1 × 10 mm) at flow rate of 80 µl/min. Samples were loaded in 15% acetonitrile, 0.05% trifluoroacetic acid, and after washing the column for 3 min after injection, proteins were eluted with
70% acetonitrile, 0.05% trifluoroacetic acid. Data were analyzed using software supplied with the instrument.
Polyacrylamide Gels--
Native gels were run in the absence of
SDS, as described previously (4, 28). Since MerP is positively charged
at pH 7.5, current flow was reversed, so the samples were run from the
anode toward the cathode. The purity of purified MerP samples was
checked using SDS-polyacrylamide gel electrophoresis (29).
Binding Studies--
Binding of Hg2+ to MerP (9 µM) was measured as described previously (4), except the
buffer used was 50 mM sodium acetate, pH 4.0. Briefly, this
binding assay is based on incubation of MerP with
203HgCl2 solutions of varying concentration
with a 4:1 ratio of cysteine:Hg to minimize nonspecific binding.
Ultrafiltration in microconcentrators (Microsep) followed by liquid
scintillation counting of 203Hg in the upper and lower
chambers allowed the concentration of MerP-bound Hg2+ to be
determined; corrections for nonspecific binding to the concentrator were determined for each HgCl2 concentration
by identical ultrafiltration experiments carried out in the absence of
MerP (4).
Data from two separate experiments were analyzed using Grafit with
non-linear least-squares fitting to the following equation to estimate
the capacity for binding Hg2+ (C), and the
apparent dissociation constant (Kd).
|
(Eq. 4)
|
y is the concentration of bound Hg2+, and
t the total concentration of added Hg2+. This
equation uses total added Hg2+, rather than the amount of
free versus bound, since the presence of cysteine in the
assay makes it difficult to estimate the concentration of free
Hg2+.
 |
RESULTS |
Electrophoretic Methods for Detecting Oxidized and Reduced Forms of
MerP--
The in vivo oxidation state of MerP has never
been reported, although only the reduced form can bind
Hg2+via Cys-14 and Cys-17 (4-6). These cysteine residues
can form a disulfide bond since reduced (MerPred) and
oxidized (MerPox) forms have been obtained by isolation of
the protein in the presence or absence of cysteine in purification
buffers (4). As is shown in Fig. 1,
purified MerPred (lane 1) and
MerPox (lane 4) have different
mobilities on a native gel; the reduced form migrates more slowly
toward the cathode (bottom) in this gel system, possibly because of
thiol group ionization at neutral pH (see below). However, in order to
preserve and identify MerPred in periplasmic extracts, it
is necessary to derivatize the free thiols prior to
electrophoresis.

View larger version (108K):
[in this window]
[in a new window]
|
Fig. 1.
Native polyacrylamide gel electrophoresis of
different forms of purified MerP: proteins were run toward the cathode
(bottom). Lane 1, MerPred;
lane 2, MerPred reacted with
iodoacetate in the presence of 5.6 M urea; lane
3, MerPred reacted with iodoacetate;
lane 4, MerPox. Reactions of MerP (28 µM) with iodoacetate (0.1 M) were conducted
at room temperature for 10 min, after which samples were placed on ice
briefly before electrophoresis. MerPred was prepared by
pre-incubation with a 50-fold excess of DTT.
|
|
Reaction with iodoacetate or iodoacetamide to trap reduced thiols and
produce proteins with altered electrophoretic mobility has been used
for a number of other thiol-containing redox proteins (see,
e.g., Refs. 15 and 21). Reaction of MerPred with
iodoacetamide resulted in the conversion of the reduced form to a
species that migrated at the position of the oxidized protein, as would
be expected by blockage of an ionized thiol group(s) with the uncharged acetamide group (data not shown). On the other hand, reaction of
reduced MerP with iodoacetate resulted in production of two slower
migrating forms (Fig. 1, lane 3). Only the most
slowly migrating form was observed over longer periods of reaction time (data not shown), or when MerP was reacted with iodoacetate in the
presence of urea (Fig. 1, lane 2). Therefore, it
appears that the two thiols on the protein are modified at quite
different rates. The observed change in mobility is consistent with the expected addition of negative charge to MerP upon carboxymethylation. No change in the mobility of oxidized MerP was observed in the presence
of iodoacetate, as would be expected if only the protein thiols were
reacting (data not shown).
The identities of the faster and slower migrating
carboxymethylated forms were examined using electrospray mass
spectrometry. A sample prepared in the presence of urea and showing
only the upper band on a native gel exhibited a single major peak with a molecular mass of 7,590; this molecular mass corresponds to that of
doubly carboxymethylated MerP (7,472 (observed) + (59 × 2)). In a
sample containing mostly the faster migrating carboxymethylated form a
species corresponding to singly carboxymethylated MerP (Mr = 7531) was the major product, and the
doubly carboxymethylated form was the minor product.
In the next section, results are described using iodoacetate to trap
and identify the reduced form of MerP from the periplasm of whole
cells. The initial observations suggesting differing accessibility and
pKa values of the two thiols will be addressed
further in later sections.
Redox State of MerP in Vivo--
In these experiments, cultures
were exposed to iodoacetate to trap the reduced form of MerP, which was
then released from the periplasm in the presence of iodoacetate and
analyzed using polyacrylamide gel electrophoresis. Similar methods have
been used for other periplasmic thiol-containing proteins (see,
e.g., Refs. 14 and 30). When MerP was expressed alone from
the T7 promoter, samples taken at various times throughout the
induction period were all mostly in the oxidized form (Fig.
2A). Similar results were
obtained when HgCl2 (20 µM) was added
together with the inducer (data not shown), indicating that the
presence of Hg2+ is not sufficient to maintain the reduced
form. However, MerP was mainly in the reduced form in periplasmic
extracts from Hg2+-resistant cells harboring the complete
operon (Fig. 2B, far left lane). In this strain, MerP remained reduced for up to 90 min after Hg2+ had been removed from the culture (Fig.
2B). Similar results for each strain were obtained using an
alternative method (15) in which cellular proteins were precipitated
with trichloroacetic acid to prevent possible nonspecific redox
reactions after cell disruption (results not shown). It should be noted
that the levels of MerP expression in the strains used for the
experiments shown in Fig. 2 are comparable, despite the differences in
the plasmid constructs. From these experiments it can be concluded that
MerP is in the reduced form in the periplasm of Hg2+
resistant cells, and that one or more of the mer
operon-encoded proteins may be involved in keeping its thiols
reduced.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Iodoacetate-trapped MerP from the periplasm
of cells expressing only MerP (A) and cells expressing
the whole mer operon (B).
Samples were prepared from equal quantities of periplasmic fractions
released in the presence of chloroform and iodoacetate, as described
under "Materials and Methods." Migration positions of wild-type
MerP (ox, red) and carboxymethylated derivatives
(ac, ac2) are indicated.
A, E. coli BL21(DE3) harboring
pCA(merP) were induced with
isopropyl-1-thio- -D-galactopyranoside and samples were
removed at 0 min (lane 1), 15 (lane
2), 30 (lane 3), 60 (lane
4), and 90 (lane 5) min after
induction. B, E. coli BL21(DE3) harboring pDU1003
were induced with HgCl2 for 90 min, at which point a sample
was taken (0 min). The remaining cells were harvested by
centrifugation, and resuspended in fresh medium at 37 °C with (+),
or without ( ), HgCl2 and including chloramphenicol (100 µg/ml) to prevent new protein synthesis. Samples were taken at the
times indicated after the 0-min sample.
|
|
Redox Properties of Purified MerP--
The apparent stability of
the reduced form of MerP in the oxidizing environment of the periplasm
prompted us to examine the redox potential of the protein. Oxidized
MerP was incubated anaerobically with various ratios of oxidized and
reduced glutathione, and the ratios of oxidized and reduced MerP were
estimated using reverse-phase HPLC after acid quench (Fig.
3). The equilibrium constant
(Kox) with glutathione was estimated to be 27 mM, which corresponds to a redox potential of
190 mV.
This value is approximately midway between the redox potentials of
oxidizing proteins such as DsbA (approximately
100 mV) (21, 31), and
reductants such as thioredoxin (
270 mV) (32).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
Determination of redox equilibrium between
MerP and glutathione. Experimental conditions and equation of the
fitted line (solid) are indicated under "Materials and
Methods."
|
|
Thiol Group pKa Values--
The reactivities of the
two thiol groups in MerP should be governed by their respective
pKa values, since the ionized thiol is more reactive
than the protonated form (33). Native gel electrophoresis results (see
above) suggested that at least one of the two thiol groups is ionized
at neutral pH. The mobilities of single cysteine variants of MerP were
thus examined using the native gel electrophoresis system, both before
and after reaction with iodoacetate (Fig.
4) or iodoacetamide (data not shown).
Since mass spectrometry indicated modification of some variants by
cysteine, or dimerization (data not shown), all samples were reduced
using DTT or TCEP prior to electrophoresis or modification. The
majority of the reduced C14S sample ran at the position of the reduced wild-type sample (Fig. 4, lane 1), while reduced
C17S mostly ran at the position of the oxidized native MerP (Fig. 4,
lane 2). Thus, it appears that it is Cys-17 which
is ionized at the pH of the gel (gel buffer pH = 7.0). Consistent
with this, C17D, unlike C17S, migrates at the position of reduced MerP
(Fig. 4, lane 3).

View larger version (83K):
[in this window]
[in a new window]
|
Fig. 4.
Electrophoretic mobility of MerP variants
(lanes 1-3) and their carboxymethylated
(CM) derivatives (lanes
4-6). Electrophoresis and modification
conditions were as described in Fig. 1 except that the proteins were
initially reduced using a 10-fold excess of TCEP, and a 40-fold excess
of DTT was added prior to electrophoresis. Lanes
1 and 4, C14S and CM-C14S; lanes
2 and 5, C17S and CM-C17S; lanes
3 and 6, C17D and CM-C17D. Migration positions of
wild-type MerP (ox, red) and carboxymethylated
derivatives (ac, ac2) are
indicated.
|
|
The electrophoretic mobilities of unmodified proteins can be compared
with the mobilities of carboxymethylated samples (Fig. 4,
lanes 4-6). The carboxymethylated and
non-carboxymethylated forms of C14S have the same mobilities (Fig.
4, lanes 1 and 4), as would be
expected if Cys-17 is already ionized. Carboxymethylation of Cys-14 in
C17S results in a complete shift to the position of reduced MerP (Fig.
4, lane 5), as would be expected for the conversion of an unionized thiol to the negatively charged
carboxymethylated derivative. Finally, carboxymethylated C17D migrates
at the same position as dicarboxymethylated MerPred (Fig.
4, lane 6). These observations add support for
the conclusion that Cys-17 is ionized at neutral pH, whereas Cys-14 is not.
Since MerP has only two thiol groups, estimation of the
pKa values is possible by pH titration and
monitoring the appearance of the thiolate forms at 240 nm (
4,000 M
1 cm
1) (17). Controls
using oxidized MerP and variants in which each thiol had been replaced
by alanine or serine allowed specific contributions of each thiol group
to the absorbance changes to be assessed. Representative results of
these titrations are shown in Fig. 5, and
pKa values are summarized in Table
I. The native reduced protein showed two
ionizations with pKa values of 5.5 and 9.16 (Fig.
5A); oxidized MerP showed no appreciable change in
absorbance over this pH range, indicating that ionization of the single
tyrosine residue does not contribute to the observed absorbance changes
(data not shown). The C14A and C14S variants showed single absorbance
changes titrating with pKa values of 6.08 and 5.8, respectively, while the C17A and C17S variants also revealed single
thiol ionizations with pKa values of 7.7 and 7.4, respectively (Table I and Fig. 5B). Thus, it appears that
the thiol with a pKa of 5.5 in native MerP is
Cys-17, while that with a pKa of 9.2 is Cys-14,
although the pKa of this thiol appears to be
considerably perturbed in the C17A and C17S variants.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
pH titrations of wild-type
(A) and variant (B) MerP. The
variant proteins in B are: C14S ( ), C17S ( ), and C17D
( ). Protein concentrations varied between 50 and 115 µM.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Summary of pKa and denaturation data for MerP and variants
Standard errors are indicated. NA, not applicable. GdmHCl, guanidinium
HCl.
|
|
A possible reason for the lowered pKa values of
Cys-14 in the C17A and C17S variants is the absence of a negative charge at residue 17 at neutral pH. Results obtained for the C17D variant showed a single thiol titrating with a pKa
of 9.1 (Fig. 5B), confirming the conclusion that it is
Cys-14 which has this pKa, and suggesting that the
presence of a negative charge at position 17 is necessary to maintain
the native-like conformation around Cys-14 in reduced MerP. In turn,
this could affect the pKa of Cys-14.
Kinetics of MerP Thiol Reaction with Iodoacetamide--
In the
initial electrophoretic analysis of modified MerP (Fig. 1), it was
apparent that the two thiol groups reacted with iodoacetate at quite
different rates. This observation is consistent with the NMR structure
of reduced MerP, which shows that Cys-14 is on the surface of the
protein while Cys-17 is buried (6). However, in addition to
accessibility, the reactivities of the thiol will also depend on the
fraction in the thiolate form. Since Cys-17 has a much lower
pKa than Cys-14, it was of interest to determine
which of the two thiols reacts rapidly with a small thiol reagent such
as iodoacetamide.
The kinetics of reaction of C17D and C14S with iodoacetamide are shown
in Fig. 6. From these data, it is clear
that Cys-14 reacts much more rapidly (kapp = 0.95 M
1 s
1, Fig. 6B)
with this small neutral thiol reagent than Cys-17
(kapp = 0.021 M
1
s
1, Fig. 6A), which is fully ionized at the pH
of the experiment. Comparable apparent second order rate constants
of 1.5 and 0.029 M
1 s
1
were observed for conversion of MerPred first to
singly and then to doubly modified protein. Correcting for the
percentage of each thiol in the anion form to obtain
kS-, the pH-independent rate constant for
reaction of the thiolate form, gave a value for Cys-14 that is 1800 times higher than that for Cys-17 in the single cysteine variants. This
indicates that Cys-17 is sterically inaccessible and very slow to
interact with external reagents despite the fact that, at pH 7.5, it is
in the very reactive thiolate form and Cys-14 is not.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 6.
Kinetics of reaction between iodoacetamide
and C14S (top) or C17D (bottom) at pH
7.5 and 25 °C. Reactions were as described under "Materials
and Methods." Second-order rate constants were estimated from the
slopes of the plots shown in the insets.
|
|
Stabilities of Oxidized, Reduced, and Variant MerP--
The
influence of structural differences between MerPox and
MerPred on protein stability were probed using guanidinium
hydrochloride denaturation studies (Fig.
7). The thermodynamic parameters obtained assuming a two-state transition are summarized in Table I. The thermodynamic parameters obtained for denaturation of
MerPox are in excellent agreement with those reported
previously (26). Changes in free energy of unfolding,

Gu50%, were calculated by
multiplying the average m-value for the two forms of MerP by
the difference in transition midpoints ([guanidinium hydrochloride]1/2) between the variant and wild-type
proteins (34). MerPred unfolded with a [guanidinium
hydrochloride]1/2 significantly higher than that observed
for the oxidized form (Fig. 7), with a

Gu50% of 0.85 kcal/mol.
MerPred is thus thermodynamically more stable than
MerPox.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Denaturation of wild type and variant MerP by
guanidinium hydrochloride. Unfolding was monitored by circular
dichroism spectroscopy, and curve-fitting to a two-state transition was
as described under "Materials and Methods." All transitions were
reversible (data not included).
|
|
The variant MerPs were generally less stable than wild-type
MerPred (Table I). The C17A and C17S variants were, like
MerPox, 0.7-0.8 kcal/mol less stable than
MerPred, but the C17D variant was not destabilized relative
to MerPred. These results support the notion that the
negative charge at position 17 is important in maintaining a
conformation more like the reduced than the oxidized form of MerP. Also
consistent with this, the stability of C14S, where ionized Cys-17 is
present, is almost identical to that of MerPred. However,
the stability of C14A is anomalously low, suggesting that the
hydrophobic alanine residue is not well tolerated at position 14.
Binding of Hg2+ at Low pH--
The finding that one of
the MerP thiol groups is ionized at neutral pH prompted us to examine
whether Hg2+ binding is affected when this thiol group is
protonated. Titration of reduced MerP (9 µM) with
Hg2+ was carried out in the presence of external cysteine,
as described previously (4) except at pH 4 (Fig.
8). The apparent Kd was 4.7 ± 1.9 µM, with a total binding capacity of
6.0 µM ± 0.6 µM (0.7 mol/mol protein).
These results are similar to those reported for pH 7.3, where the
apparent Kd and binding capacity using 10 µM MerP were 3.7 ± 1.3 and 8.8 ± 0.6 µM (0.88 mol/mol protein), respectively (4).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 8.
Binding of Hg2+ to MerP at pH
4. The assay contained the following components: 50 mM
sodium acetate buffer, pH 4.0, 9 µM reduced MerP,
HgCl2 (including 203HgCl2) in
varying concentrations, and cysteine in a 4-fold excess over
HgCl2. The amount of bound versus total
Hg2+ (solid line) was estimated using
the fitting procedure described in the text.
|
|
 |
DISCUSSION |
The role of periplasmic MerP in mercuric ion resistance is
postulated to be scavenging of mercuric ion via the heavy metal binding
motif, GMTC14XXC17, for later
transfer to Hg2+ translocating membrane proteins.
Consistent with this role, MerP with both Cys-14 and Cys-17 reduced has
been shown to bind mercuric ion with high affinity, even in the
presence of excess free cysteine (4-6). Since MerP is readily isolated
in the oxidized form, with a disulfide formed between Cys-14 and
Cys-17, the reactivity of these thiol groups is an important
determinant of the Hg2+ binding role of MerP.
Since various redox catalysts (the Dsb proteins) active with protein
thiols/disulfides are present in the bacterial periplasm (reviewed in
Ref. 10), a relevant question is whether MerP in vivo exists
in the dithiol, Hg2+-binding form. Trapping experiments
established that in the absence of expression of the other proteins of
the mer operon, periplasmic MerP was mainly oxidized, while
in cells expressing the complete operon, MerP was mainly in the reduced
form. Thus, in mercuric ion-resistant cells, periplasmic MerP indeed
exists in the Hg2+-binding dithiol form despite the
presence of DsbA, a disulfide bond-forming catalyst. Our experiments
indicate that Hg2+ is not required to maintain MerP in the
reduced form. The observation that MerP was mainly in the oxidized form
when expressed alone suggests the possibility that association with
other mer operon proteins is important to preserve the
reduced form, but this has not been confirmed.
The reduced form of MerP was found to be thermodynamically more stable
than the oxidized form. While disulfide bonds in proteins are generally
considered to be a stabilizing influence, in some cases they are
destabilizing. A well known example of a destabilizing disulfide bond
is the one found in DsbA (21). Unfolding experiments showed
stabilization of MerPred relative to the oxidized form, with 
Gu50% = 0.85 kcal/mol.
Unfolded MerPox is theoretically 1.86 kcal/mol less stable
than the unfolded reduced form, assuming that the only difference
between the unfolded forms (35) is the reduced entropy associated with
the 4-amino acid loop present in MerPox. Taking this into
account, the overall difference in free energy between the reduced and
oxidized forms of MerP is calculated to be about 2.7 kcal/mol.
A number of factors appear to be important for stabilizing
MerPred relative to the oxidized form. One of these is the
unusually low pKa, 5.5, of the cysteine thiol at
position 17. Its absence in C17S and C17A resulted in variants with
stabilities similar to MerPox rather than to
MerPred. Interestingly, the Cys-14 thiol
pKa was also perturbed when Cys-17 was replaced by
alanine or serine; this may be a result of structural changes occurring
upon loss of the negative charge at position 17. Consistent with these
notions, a variant in which Cys-17 was replaced with aspartate,
preserving the negative charge, was almost as stable as the reduced
form, and the Cys-14 thiol pKa was not affected.
Furthermore, the observation by NMR spectroscopy (36) that low pH
alters the structure of MerPred, but not
MerPox, provides additional support for the proposal that a
negative charge at position 17 helps to maintain the structure. The
lowering to 5.5 of the pKa of the Cys-17 thiol from
a more typical 8.7 would be expected to stabilize MerPred
by 4.3 kcal/mol, which is greater than the observed value of 2.7 kcal/mol. However, the conformational change in going from reduced to
oxidized MerP involves movement of Cys-17 from a buried to exposed
position and other associated structural changes that amount to more
than simple removal of a thiolate (6, 36). Thus, the low
pKa of Cys-17 is not the sole determinant of the
relative stabilities of MerPox and MerPred.
Like MerP, proteins such as thioredoxin, protein-disulfide isomerase
and DsbA contain a pair of redox-active cysteines separated by two
amino acid residues. The ability of proteins to oxidize reduced
glutathione, as reflected in the equilibrium constant, Kox, provides a way of comparing their redox
properties (19). The Kox of 27 mM
obtained for MerP is between those for DsbA (approximately 0.1 mM) (21, 31), a strongly oxidizing protein, and thioredoxin (10 M) (37), a strongly reducing protein. Furthermore,
studies of DsbA have indicated that there is a relationship between
Kox and the pKa of the
leaving group thiol in the disulfide. The experimentally obtained
Kox for MerP is very similar to what what would
be expected for a leaving group pKa of 5.5 (see Fig.
4 in Ref. 38), so this relationship appears to extend to MerP as well.
However, it does not necessarily hold for all proteins with a
CXXC motif (39).
Lowering of cysteine thiol pKa values in a
-C-X-X-C- motif has been reported for proteins
such as DsbA, for which a pKa of approximately 3.5 has been reported (40). The low pKa thiols of both
DsbA and MerP are situated at the amino-terminal ends of
-helices.
Stabilization of the negatively charged thiolate anion by the helix
dipole lowers the pKa (41), but in model
-helical
peptides this can only account for a lowering of the thiol
pKa by up to 1.6 units (42). It is interesting to
note that it is only in the reduced form of MerP that Cys-17 is part of
the
-helix, whereas in the oxidized and Hg2+-bound forms
the
-helix starts at residues 18 and 19, respectively (6, 36). A
second thiolate-stabilizing feature of both thioredoxin and DsbA is
hydrogen bonding of backbone amides to the sulfur of the
low-pKa thiol (43, 44). In reduced MerP, the amide
of M12 appears to be close enough to hydrogen bond with, and stabilize
the thiolate of MerP. In the set of 20 NMR structures of reduced MerP,
the S-amideNMet12 and S-amideHMet12 average
distances are 3.24 and 2.61 Å, respectively, within the limits of
3.25-3.55 and 2.3-2.6 Å, respectively, expected for S-N H-bonds (45,
46). Unlike in DsbA, where His-32 appears to help stabilize the
thiolate anion at C30 (38, 44), there are no charged residues in the vicinity of Cys-17 in MerP.
Another key feature of Cys-17 is its inaccessibility as measured by
reactivity with iodoacetamide, a neutral solvent-borne thiol-reactive
reagent. Thus, the intrinsic reactivity of Cys-17 thiolate with
iodoacetamide is 1800 times lower than Cys-14 thiolate. This is
consistent with the structure of MerPred, which shows that
Cys-14 is exposed on the surface while Cys-17 is buried (6). As
discussed earlier, the low pKa of the Cys-17 thiol appears to help stabilize MerPred relative to
MerPox, maintaining the protein in a form competent for
Hg2+ binding. By keeping ionized Cys-17 away from the
surface of the protein, undesirable reactions of this group, such as
thiol exchange or oxidation, would also be minimized; surface-exposed
Cys-14, which is not ionized at neutral pH, is not so susceptible to
undesirable side reactions. Furthermore, by keeping the thiol groups
well apart in the reduced protein, conversion to the oxidized form would be minimized.
A C-X-X-C motif with a low pKa
thiol has been well characterized in redox proteins such as thioredoxin
and DsbA. In these proteins it is the exposed thiol in the cysteine
redox pair that has a lowered pKa (43, 44). This is
undoubtedly related to the disulfide-exchange mechanism of these
proteins, where a nucleophilic cysteine initiates attack on the
polypeptide substrate (47). By contrast, the MerP
C-X-X-C motif appears to be specialized for metal binding.
While the separation of thiol groups may be important in keeping MerP
reduced and competent to bind Hg2+, how can both thiols
become coordinated to mercuric ion as has been indicated by NMR
experiments (6)? A comparison of the structures of free and
Hg2+-liganded MerP indicates that Cys-17 migrates to the
surface of the protein, in the process partially unravelling the amino
terminus of the
-helix of which it is a part (6); a similar
structural change is observed after formation of MerPox
(36). A possible mechanism for this might be that Hg2+
initially binds to Cys-14 at the surface of the protein and then attracts the negatively charged thiol from its inaccessible position. The structural change that results may be important to allow loaded MerP to dock with one of the Hg2+-transporting proteins (6,
7), but experimental evidence for docking is currently lacking.
The importance of Cys-17 thiol deprotonation for equilibrium binding of
Hg2+ was investigated by examining mercuric ion binding at
pH 4, where this residue is mostly un-ionized. These binding studies,
carried out in the presence of competing cysteine ligand to minimize
nonspecific binding, indicated little difference in binding parameters
at pH 4 versus pH 7.3. This is not too surprising, since
dissociation constants for Hg2+(thiol)2
complexes are on the order 10
40 over a range of pH values
(48). Therefore, it follows that the experimentally determined apparent
Kd values are dominated by competitive
Hg2+ binding to cysteine and MerP thiols, and would be
unperturbed by the relatively insignificant contribution of the
equilibrium between protonated and deprotonated thiols at pH 4 versus pH 7.3. In other words, extremely tight binding of
Hg2+ to the deprotonated form would shift the equilibrium
from the protonated form to the Hg complex. Indeed, NMR data for
bidentate binding of Hg2+ to glutathione thiols showed that
binding was tight over the pH range 1-13 (49). It therefore may be
concluded that a fully deprotonated Cys-17 thiol is not essential for
equilibrium Hg2+ binding, although a role for the Cys-17
thiolate in influencing Hg2+-binding kinetics cannot be
ruled out by our data. Instead, its influence on MerP structure, and
possibly structural change upon Hg2+ binding, are much more significant.
The low pKa of Cys-17 may also play an important
role in release of Hg2+ from MerP to the mercuric ion
transport proteins, MerT and/or MerC. NMR studies have demonstrated
that Hg2+ is rapidly exchanged among thiol ligands, such as
those in Hg(glutathione)2, via transient formation of an
Hg(thiol)3 complex (50). If transfer of Hg2+
from MerP to a thiol pair on MerT or MerC occurs via an
Hg(thiol)3 complex, the low pKa of
Cys-17 relative to the other two thiol pKa values
would favor it as a leaving group. However, it must be noted that
despite its attractiveness as a hypothesis, evidence is currently
lacking for direct transfer of Hg2+ between thiol pairs on
different Mer proteins.
It is interesting to note that, although the structure of the
metal-binding domain of the Menkes copper-transporting ATPase is very
similar to that of MerP, no conformational change was observed upon
metal ion binding to a Menkes domain (51). Furthermore, Cys-17 in the
Menkes protein is exposed to solvent, and is thus unlikely to have a
perturbed pKa as in MerP. Use of the MTCXXC heavy metal binding motif to engineer metal binding
sites into proteins thus may need to take into account the context of the cysteine residues to help control metal binding reactivity.
 |
ACKNOWLEDGEMENTS |
We thank Craig Fenwick for mass spectrometry
measurements and Simon Silver for a gift of pDU1003. Jack and Judy
Kornblatt made many useful comments on the manuscript.
 |
FOOTNOTES |
*
This work was supported by an operating grant from the
Natural Sciences and Engineering Research Council of Canada (to J. P.). This work was initiated during a sabbatical visit (by J. P.)
to the Department of Biochemistry, Umeå University, Sweden.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Chemistry and
Biochemistry, Concordia University, 1455 de Maisonneuve Blvd. W.,
Montreal, Quebec H3G 1M8, Canada. Tel.: 514-848-8727; Fax:
514-848-2868; E-mail: powlow@vax2.concordia.ca.
 |
ABBREVIATIONS |
The abbreviations used are:
DTT, dithiothreitol;
MerPox, oxidized MerP (disulfide form);
MerPred, reduced MerP (dithiol form);
MES, 2-(N-morpholino)ethanesulfonic acid;
TCEP, tris-(2-carboxyethyl)phosphine;
HPLC, high performance liquid
chromatography.
 |
REFERENCES |
| 1.
|
Summers, A. O.
(1986)
Annu. Rev. Microbiol.
40,
607-634[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Silver, S.,
and Phung, L. T.
(1996)
Annu. Rev. Microbiol.
50,
753-789[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Barrineau, P.,
Gilbert, P.,
Jackson, W. J.,
Jones, C. S.,
Summers, A. O.,
and Wisdom, S.
(1984)
J. Mol. Appl. Genet.
2,
601-619[Medline]
[Order article via Infotrieve]
|
| 4.
|
Sahlman, L.,
and Jonsson, B.-H.
(1992)
Eur. J. Biochem.
205,
375-381[Medline]
[Order article via Infotrieve]
|
| 5.
|
Sahlman, L.,
and Skärfstad, E. G.
(1993)
Biochem. Biophys. Res. Commun.
196,
583-588[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Steele, R. A.,
and Opella, S. J.
(1997)
Biochemistry
36,
6885-6895[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Brown, N. L.
(1985)
Trends Biochem. Sci.
10,
400-403[CrossRef]
|
| 8.
|
Morby, A. P.,
Hobman, J. L.,
and Brown, N. L.
(1995)
Mol. Microbiol.
17,
25-35[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Sahlman, L.,
Wong, W.,
and Powlowski, J.
(1997)
J. Biol. Chem.
272,
29518-29526[Abstract/Free Full Text]
|
| 10.
|
Raina, S.,
and Missiakis, D.
(1997)
Annu. Rev. Microbiol.
51,
179-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Rosenburg, A. H.,
Lade, B. N.,
Chui, S.,
Lin, S.,
Dunn, J. J.,
and Studier, F. W.
(1987)
Gene (Amst.)
56,
125-135[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Ni'Bhriain, N.,
Silver, S.,
and Foster, T. J.
(1983)
J. Bacteriol.
155,
690-703[Abstract/Free Full Text]
|
| 13.
|
Ames, G. F.-L.,
Prody, C.,
and Kustu, S.
(1984)
J. Bacteriol.
160,
1181-1183[Abstract/Free Full Text]
|
| 14.
|
Guilhot, C.,
Jander, G.,
Martin, N. L.,
and Beckwith, J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9895-9899[Abstract/Free Full Text]
|
| 15.
|
Kishigami, S.,
Akiyama, Y.,
and Ito, K.
(1995)
FEBS Lett.
364,
55-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Gill, S. C.,
and von Hippel, P. H.
(1989)
Anal. Biochem.
182,
319-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Polgár, L.
(1974)
FEBS Lett.
38,
187-190[CrossRef]
|
| 18.
|
Ellis, K. J.,
and Morrison, J. F.
(1982)
Methods Enzymol.
87,
405-426[Medline]
[Order article via Infotrieve]
|
| 19.
|
Gilbert, H. F.
(1995)
Methods Enzymol.
251,
8-28[Medline]
[Order article via Infotrieve]
|
| 20.
|
Hawkins, H. C.,
de Nardi, M.,
and Freedman, R. B.
(1991)
Biochem. J.
275,
341-348
|
| 21.
|
Zapun, A.,
Bardwell, J. C. A.,
and Creighton, T. E.
(1993)
Biochemistry
32,
5083-5092[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Rost, J.,
and Rapoport, S.
(1964)
Nature
201,
185
|
| 23.
|
Nozaki, Y.
(1972)
Methods Enzymol.
26,
43-50
|
| 24.
|
Santoro, M. M.,
and Bolen, B. W.
(1988)
Biochemistry
27,
8063-8068[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Pace, C. N.,
Shirley, B. R.,
and Thomson, J. A.
(1990)
in
Protein Structure: A Practical Approach
(Creighton, T. E., ed)
, pp. 311-330, IRL Press, Oxford, United Kingdom
|
| 26.
|
Aronsson, G.,
Brorsson, A.-C.,
Sahlman, L.,
and Jonsson, B. H.
(1997)
FEBS Lett.
411,
359-364[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Riddles, P. W.,
Blakely, R. L.,
and Zerner, B.
(1983)
Methods Enzymol.
91,
49-60[Medline]
[Order article via Infotrieve]
|
| 28.
|
Hamlett, N. V.,
Landale, E. C.,
Davis, B. H.,
and Summers, A. O.
(1992)
J. Bacteriol.
174,
6377-6385[Abstract/Free Full Text]
|
| 29.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Bardwell, J. C.,
Lee, J. O.,
Jander, G.,
Martin, N.,
Belin, D.,
and Beckwith, J.
(1993)
Proc. Nat. Acad. Sci. U. S. A.
90,
1038-1042[Abstract/Free Full Text]
|
| 31.
|
Wunderlich, M.,
and Glockshuber, R.
(1993)
Protein Sci.
2,
717-726[Abstract]
|
| 32.
|
Moore, E. C.,
Reichard, P.,
and Thelander, L.
(1964)
J. Biol. Chem.
239,
3445-3452[Free Full Text]
|
| 33.
|
Lindley, H.
(1960)
Biochem. J.
74,
577-584[Medline]
[Order article via Infotrieve]
|
| 34.
|
Serrano, L.,
Kellis, J. T.,
Cam, P.,
Matouschek, A.,
and Fersht, A. R.
(1992)
J. Mol. Biol.
224,
783-804[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Pace, C. N.,
Grimsley, G. R.,
Thomson, J. A.,
and Barnett, B. J.
(1988)
J. Biol. Chem.
263,
11820-11825[Abstract/Free Full Text]
|
| 36.
|
Qian, H.,
Sahlman, L.,
Eriksson, P.-O.,
Hambraeus, C.,
Edlund, U.,
and Sethson, I.
(1998)
Biochemistry
37,
9316-9322[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Lin, T.-Y.,
and Kim, P. S.
(1989)
Biochemistry
28,
5282-5287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Grauschopf, U.,
Winther, J. R.,
Korber, P.,
Zander, T.,
Dallinger, P.,
and Bardwell, J. C. A.
(1995)
Cell
83,
947-955[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Chivers, P. T.,
Prehoda, K. E.,
and Raines, R. T.
(1997)
Biochemistry
36,
4061-4066[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Nelson, J. W.,
and Creighton, T. E.
(1994)
Biochemistry
33,
5974-5983[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Hol, W. G.
(1985)
Prog. Biophys. Mol. Biol.
45,
149-195[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Kortemme, T.,
and Creighton, T. E.
(1995)
J. Mol. Biol.
253,
799-812[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Katti, S. K.,
LeMaster, D. M.,
and Eklund, H.
(1990)
J. Mol. Biol.
212,
167-184[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Guddat, L. W.,
Bardwell, J. C. A.,
and Martin, J. L.
(1998)
Structure
6,
757-767[Abstract/Free Full Text]
|
| 45.
|
Adman, E.,
Watenpaugh,
and Jensen, L. H.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
4854-4858[Abstract/Free Full Text]
|
| 46.
|
Donohue, J.
(1969)
J. Mol. Biol.
45,
231-235[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Holmgren, A.
(1995)
Structure
3,
239-243[Medline]
[Order article via Infotrieve]
|
| 48.
|
Stricks, W.,
and Kolthoff, I. M.
(1953)
J. Am. Chem. Soc.
75,
5673-5681[CrossRef]
|
| 49.
|
Fuhr, B. J.,
and Rabenstein, D. L.
(1973)
J. Am. Chem. Soc.
95,
6944-6950[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Cheesman, B. V.,
Arnold, A. P.,
and Rubenstein, D. L.
(1988)
J. Am. Chem. Soc.
110,
6359-6364[CrossRef]
|
| 51.
|
Gitschier, J.,
Moffat, B.,
Reilly, D. J.,
Wood, W. I.,
and Fairbrother, W. J.
(1998)
Nat. Struct. Biol.
5,
47-54[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us